71 results on '"McLaughlin, Peter"'
Search Results
2. „Ordnung und Organisation“. Interview zur Historiographie der Biologie mit Hans‐Jörg Rheinberger und Peter McLaughlin**
3. Application Theme 2 – Groundwater Evaluations
4. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma
5. Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma
6. Impact of the timing of hepatitis B virus identification and anti–hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy
7. High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study
8. Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model
9. Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity
10. Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
11. Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma
12. Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas
13. Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
14. 90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease
15. Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma
16. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non‐Hodgkin lymphomas
17. Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
18. Non‐Hodgkin Lymphomas
19. Marginal zone lymphomas
20. Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma
21. Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma
22. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma
23. Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma
24. 100 Myr record of sequences, sedimentary facies and sea level change from Ocean Drilling Program onshore coreholes, US Mid-Atlantic coastal plain
25. Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
26. Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B‐cell non‐Hodgkin lymphoma
27. Meta–analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics
28. Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma
29. Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma
30. Transcatheter closure of aortic sinus to left atrial fistula caused by erosion of amplatzer septal occluder
31. Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
32. Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen
33. Thalidomide for patients with recurrent lymphoma
34. Case of aortic rupture with stenting
35. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance
36. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy
37. Aortic dissection after stent dilatation for coarctation of the aorta: A case report and literature review
38. A pilot study of rituximab in patients with recurrent, classic Hodgkin disease
39. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma
40. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect
41. Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma
42. Gamow u. Stannard.: The New World of Mr. Tompkins/Porter.: Physicists in Conflict/Hertz.: Die Constitution der Materie. Eine Vorlesung über die Grundlagen der Physik aus dem Jahre 1884/Guicciardini.: Reading the Principia. The Debate on Newton's Mathemati
43. Paclitaxel plus high-dose cyclosphosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma
44. Diabetes Atherosclerosis Intervention Study (DAIS): Quantitative coronary angiographic analysis of coronary artery atherosclerosis
45. Monoclonal Antibodies: How to Use Them in Practice
46. Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial
47. Ninety-one Cases of Breast Cancer and Chronic Lymphoproliferative Neoplasm: A Retrospective Review of a Population at High Risk for Multiple Malignancies
48. Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type
49. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma
50. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.